Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment.
about
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialOverview of treatment related complications in malignant pleural mesothelioma.Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a "common language" for the new arena of cancer treatment.Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients.Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.Monitoring immune-checkpoint blockade: response evaluation and biomarker development.Checkpoint Inhibitors for the Treatment of Hodgkin Lymphoma.Cancer Imaging in Immunotherapy.Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course.Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions.Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy.Key questions about the checkpoint blockade-are microRNAs an answer?The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
P2860
Q30277192-3F73D113-220C-4BCA-AB7E-C381E98B3AA0Q33871599-26FADE44-C11D-4477-8F3D-7CB58A71E972Q36759340-E9C67DDB-96BA-496B-87CE-A680A4865BC4Q37024590-4868A0E0-FCA2-4029-9E3D-3CAA01729153Q37516943-FD386250-49DD-4AC7-8FA2-FB0E7988AFF6Q37589557-DDEC06B7-B5B9-4E7A-9D7B-D6F7A1500572Q38666241-FE595E4D-137C-4EE2-AF88-BA18AF5DACA3Q38714437-A160A068-9034-4CAF-80A3-784F66728BCFQ39189252-07FEFF60-8AD1-4B2D-884E-6C5CDE13D35BQ39350373-9A36EACD-5384-4B9F-A31A-61813F65CFA6Q46320590-A9FD3FB4-24E1-4F9F-A751-723A439EE6C5Q48771882-18046427-8B26-4763-B741-B309F0E4632FQ50133191-129149ED-AA75-4085-A41E-E9FC228195B9Q52580666-D8C0A757-7B48-47B8-9F92-4EA9FF902038Q55339993-D4606D65-C9CC-469C-ADDB-7B5F45A3D51DQ55717841-32037D26-2E3C-44F8-84A5-1210AE949B94
P2860
Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@ast
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@en
type
label
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@ast
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@en
prefLabel
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@ast
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@en
P2093
P2860
P1476
Cancer immunotherapy and immun ...... new arena of cancer treatment.
@en
P2093
F Stephen Hodi
Mizuki Nishino
Nikhil H Ramaiya
Sree H Tirumani
P2860
P304
P356
10.1016/J.EJRAD.2015.03.017
P577
2015-03-23T00:00:00Z